Search for: "State v. Janssen" Results 121 - 140 of 239
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 May 2017, 3:23 am by Kluwer UPC News blogger
The practical effect of the Supreme Court’s decision in Heartland v Kraft Foods will be to restrict a patentee’s choice to bring cases in patentee-friendly jurisdictions where findings of infringement and damages awards are higher than in other venues, namely the Eastern District of Texas. [read post]
6 Jul 2007, 4:29 am
We've already deplored the recent decision of the West Virginia Supreme Court rejecting the learned intermediary rule outright, State ex rel. [read post]
6 Jul 2012, 9:56 am
Twombly, 550 U.S. 544 (2007), and Ashcroft v. [read post]
25 Jan 2021, 1:31 am by Rose Hughes
 The difference between the state of the art and the claimed invention was that the prior art did not specify administration of 40 mg glatiramer acetate every other day, three times a week. [read post]
4 Mar 2008, 1:49 am
Janssen, discussing the new Federal Rules of Civil Procedure and their impact on litigators can be downloaded at [feeds.feedburner]. com/Westcast. [read post]
24 Feb 2016, 5:14 am
Janssen Pharmaceuticals, Inc., 2016 WL 633673 (E.D. [read post]
26 Jul 2017, 3:49 am by Miquel Montañá
As explained in paragraph 42 of this judgment, in paragraph 37 of Kirin-Amgen Inc v Hoechst Marion Roussel Ltd [2005] RPC 9, Lord Hoffmann explained that the doctrine of equivalents had been developed in the United States. [read post]
26 Jul 2017, 3:49 am by Miquel Montañá
As explained in paragraph 42 of this judgment, in paragraph 37 of Kirin-Amgen Inc v Hoechst Marion Roussel Ltd [2005] RPC 9, Lord Hoffmann explained that the doctrine of equivalents had been developed in the United States. [read post]